MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Royal DSM N.V.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DSM and Rostekhnologii to Cooperate on Biotechnology and Functional Materials - Royal DSM announces that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with Rostekhnologii (Rostec), a Russian State Corporation, in the fields of biotechnology and functional materials - DSM.com
DSM and Rostekhnologii to Cooperate on Biotechnology and Functional Materials

 

NewswireToday - /newswire/ - Heerlen, Netherlands, 2013/04/08 - Royal DSM announces that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with Rostekhnologii (Rostec), a Russian State Corporation, in the fields of biotechnology and functional materials - DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with Rostekhnologii (Rostec), a Russian State Corporation, in the fields of biotechnology and functional materials. The MOU was signed today in Amsterdam (Netherlands) in the presence of President Vladimir Putin of the Russian Federation and Prime Minister Mark Rutte of the Netherlands.

Under the terms of the MOU, DSM and Rostec will explore a potential cooperation in the field of conversion of cellulosic biomass from forestry and agriculture to fermentable sugars for the production of biofuels and/or biobased chemicals as well as the manufacturing of bio-based products such as bioethanol, biogas and organic acids from sugars derived from cellulosic biomass.

DSM and Rostec will also explore to cooperate in the area of enhancing the performance of Russia’s fast expanding optical fiber networks using DSM’s UV-curable resins optical fiber materials. In addition, DSM Dyneema and RT-Chemcomposite, part of Rostec, will investigate the establishment of a joint venture for the production and sales of Uni-Directional products based on Ultra High Molecular Weight PE-fibers in Russia using DSM’s proprietary technology for life protection applications.

Vladimir Artyakov, Deputy CEO of Rostekhnologii, said: “The cooperation with DSM will accelerate the process of introducing new, unique products in the Russian market to be used in different areas, including biotechnology and functional materials. The partnership with DSM is strategic and intended for the long term.”

Feike Sijbesma, Chief Executive Officer and Chairman of the DSM Managing Board, said: “As 2013 was declared a year of friendship between the Netherlands and Russia, this is a perfect occasion to explore opportunities for further cooperation between DSM and Russia. With two joint ventures already in place, I am looking forward to a successful cooperation in several important business areas including the development of advanced biofuels with Rostec.”

For DSM, Russia is one of the High Growth Economies the company is focusing on in executing its strategy DSM in motion: driving focused growth. DSM’s main business areas in Russia are food and feed ingredients, pharmaceutical intermediate products, biotechnology, fiber materials, resins and engineering plastics. Through its business activities, DSM meets the needs and trends in the Russian Federation, including localization (import substitution), modernization in technologies and diversification (less oil dependence). In 2012, DSM celebrated 20 years of presence in Russia.

In 2010 DSM (dsm.com) started a joint venture in Tatarstan to contribute to Russia’s goal of reaching a higher self-sufficiency in animal protein production and supply by securing better animal nutrition. In 2011 DSM entered into a long-term partnership in the area of engineering plastics with JSC KuibyshevAzot in Tolyatti (Samara Region) in order to supply locally produced products to the automotive and electrical & electronics industries.

Rostec
State Corporation Russian Technologies (Rostec) is a Russian corporation established in 2007 in order to facilitate the development, manufacturing and export of high-technology industrial products. Today it comprises about 663 companies with activities ranging from automotive to aviation, building, electronics, telecommunications and defense technology. Rostec’s subsidiaries are located in 60 regions of the Russian Federation and supply their products to over 70 countries worldwide. In 2012 net sales amounted to RUB 963 billion (~€ 24 billion) with more than 900,000 employees.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DSM and Rostekhnologii to Cooperate on Biotechnology and Functional Materials

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Herman Betten - DSM.com 
+31(0)45 5782017 media.relations[.]dsm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Royal DSM N.V. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)